# Trevi Therapeutics, Inc.: Form 8-K, filed Aug 8, 2024

- Company: [Trevi Therapeutics, Inc.](/companies/trvi.md) (CIK 1563880)
- Form: 8-K
- Filed: 2024-08-08
- Accepted by EDGAR: Aug 8, 2024, 16:09 ET
- Period: 2024-08-08
- Accession: 0000950170-24-093942
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1563880/000095017024093942/trvi-20240808.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1563880/000095017024093942/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1563880/000095017024093942/trvi-20240808.htm

Filed Aug 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-093942. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.